Regulation of Human NHE3 by Ubiquitination

泛素化对人类 NHE3 的调控

基本信息

  • 批准号:
    9335349
  • 负责人:
  • 金额:
    $ 35.1万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-09-01 至 2020-06-30
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY Diarrheal disease causes close to one million deaths in children under five each year. Although its incidence is much lower in the more affluent nations, diarrhea remains one of the two most common visits to pediatric emergency rooms and is also common among the institutionalized elderly. NHE3 is a major sodium transporter in the brush border membrane of the small intestine and proximal colon. Abnormal NHE3 expression and function are associated with diarrheal diseases resulting from acute pathogenic infection and inflammation in the gut. This application aims at understanding post-translational modification of human NHE3. The impetus of the proposed study comes from our recent finding that NHE3s of human and primates differ from NHE3s of lower mammals, including rodents and rabbits. Nedd4-2 is an E3 ubiquitin ligase that interacts with substrate proteins via PY (PPxY) motif. We found that human NHE3 (hNHE3) interacts with Nedd4-2, which ubiquitinates hNHE3 and mediates endocytosis, and the response of hNHE3 is much greater to forskolin/PKA than rabbit NHE3. Although mice have widely been used to understand the physiological role of NHE3, mice are relatively resistant to development diarrhea. We will examine the idea that ubiquitination of hNHE3 contributes to the increased severity of acute diarrhea in man. To begin, we will compare the regulation of hNHE3 and mouse NHE3 in vivo using transgenic animals. We will study how hNHE3 is endocytosed, recycled and degraded by Nedd4-2 mediated ubiquitination. Ubiquitination is counteracted by deubiqutination. We have identified several putative deubiquinating enzymes (DUBs) that interact with hNHE3. We plan to investigate how Nedd4-2 and DUBs dynamically regulated hNHE3. Our work is expected to reveal new mechanism for the control of intestinal brush border NHE3, and identify Nedd4-2 as a novel target for the therapeutic of diarrheal diseases caused by abnormal sodium and water balance in intestinal epithelium.
项目摘要 腹泻病每年造成近100万5岁以下儿童死亡。虽然它的发病率是 在较富裕的国家,腹泻仍然是儿科最常见的两种疾病之一, 急诊室,也是常见的机构老人。NHE 3是一种主要的钠转运蛋白 在小肠和近端结肠的刷状缘膜中。NHE 3表达异常, 功能与急性病原性感染和炎症引起的呼吸道疾病有关, 内脏本申请旨在理解人NHE 3的翻译后修饰。的推动 这项拟议的研究来自于我们最近的发现,即人类和灵长类动物的NHE 3与人类的NHE 3不同。 低等哺乳动物,包括啮齿动物和兔子。Nedd 4 -2是一种E3泛素连接酶, 通过PY(PPxY)基序的蛋白质。我们发现人NHE 3(hNHE 3)与Nedd 4 -2相互作用, hNHE 3介导内吞作用,并且hNHE 3对forskolin/PKA的反应比兔大得多 NHE3。虽然小鼠已被广泛用于了解NHE 3的生理作用,但小鼠相对较弱。 对腹泻有抵抗力。我们将研究hNHE 3的泛素化有助于 开始,我们将比较hNHE 3和小鼠的调节作用, 使用转基因动物的体内NHE 3。我们将研究hNHE 3是如何内吞,回收和降解, Nedd 4 -2介导的泛素化。泛素化被去泛素化抵消。我们发现了几个 与hNHE 3相互作用的推定的去泛素化酶(DUB)。我们计划调查Nedd 4 -2和 DUBs动态调节hNHE 3。我们的工作有望揭示新的控制机制, 肠刷状缘NHE 3,并将Nedd 4 -2鉴定为治疗结肠炎疾病的新靶点 由肠上皮细胞中的钠和水平衡异常引起。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Changhyon Chris Yun其他文献

Changhyon Chris Yun的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Changhyon Chris Yun', 18)}}的其他基金

Role of Na+/H+ exchanger in diabetic diarrhea
Na /H 交换剂在糖尿病腹泻中的作用
  • 批准号:
    9780816
  • 财政年份:
    2019
  • 资助金额:
    $ 35.1万
  • 项目类别:
Role of Na+/H+ exchanger in diabetic diarrhea
Na /H 交换剂在糖尿病腹泻中的作用
  • 批准号:
    10516034
  • 财政年份:
    2019
  • 资助金额:
    $ 35.1万
  • 项目类别:
Role of Na+/H+ exchanger in diabetic diarrhea
Na /H 交换剂在糖尿病腹泻中的作用
  • 批准号:
    10044405
  • 财政年份:
    2019
  • 资助金额:
    $ 35.1万
  • 项目类别:
Role of Na+/H+ exchanger in diabetic diarrhea
Na /H 交换剂在糖尿病腹泻中的作用
  • 批准号:
    10292922
  • 财政年份:
    2019
  • 资助金额:
    $ 35.1万
  • 项目类别:
The function of lysophosphatidic acid receptor LPA5R in intestinal inflammation and epithelial damage
溶血磷脂酸受体LPA5R在肠道炎症和上皮损伤中的作用
  • 批准号:
    10163842
  • 财政年份:
    2018
  • 资助金额:
    $ 35.1万
  • 项目类别:
The function of lysophosphatidic acid receptor LPA5R in intestinal inflammation and epithelial damage
溶血磷脂酸受体LPA5R在肠道炎症和上皮损伤中的作用
  • 批准号:
    9927619
  • 财政年份:
    2018
  • 资助金额:
    $ 35.1万
  • 项目类别:
The function of lysophosphatidic acid receptor LPA5R in intestinal inflammation and epithelial damage
溶血磷脂酸受体LPA5R在肠道炎症和上皮损伤中的作用
  • 批准号:
    10406933
  • 财政年份:
    2018
  • 资助金额:
    $ 35.1万
  • 项目类别:
Regulation of intestinal homeostasis and epithelial barrier by LPA
LPA 对肠道稳态和上皮屏障的调节
  • 批准号:
    9337341
  • 财政年份:
    2015
  • 资助金额:
    $ 35.1万
  • 项目类别:
Regulation of intestinal homeostasis and epithelial barrier by LPA
LPA 对肠道稳态和上皮屏障的调节
  • 批准号:
    8820221
  • 财政年份:
    2015
  • 资助金额:
    $ 35.1万
  • 项目类别:
LPA receptor signaling in colonic epithelia
结肠上皮细胞中的 LPA 受体信号传导
  • 批准号:
    7921162
  • 财政年份:
    2009
  • 资助金额:
    $ 35.1万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.1万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 35.1万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.1万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.1万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.1万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.1万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.1万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 35.1万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 35.1万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 35.1万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了